RxDoctor Payments DataLook up a doctor →

Jennifer Jonkers, MD

Geriatric Medicine · Abingdon, VANPI 1548339989

Payments from drug & device makers

$8,015in general payments, 2019–2025

Across 471 payments — averaging $17.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$1K
  • GSK$946
  • Novo Nordisk$841
  • Amgen$612
  • Johnson & Johnson$598
  • Abbott$537
  • plus $3K from 37 others

What the payments were for

  • Food & beverage$8,015100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,015 in reported general payments places this provider in the 95th percentile of 90 geriatric medicine providers in Virginia.

See all geriatric medicine providers in Virginia

Medicare billing

Part B allowed, 2024
$217,317
Medicare patients
359
Services billed
3,049

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
AbrysvoRsv Vacc, Pref A And Pref B/Pf2,934$893,901
ShingrixVaricella-Zoster Ge/As01b/Pf2,319$490,157
EliquisApixaban174$159,360
ArexvyRsvpref3 Antigen/As01e/Pf277$82,728
Boostrix TdapDiphth,pertuss(Acell),tet Vac1,142$74,337
JardianceEmpagliflozin83$69,219
JanuviaSitagliptin Phosphate76$62,915
OzempicSemaglutide48$54,743
FarxigaDapagliflozin Propanediol53$50,960
Trelegy ElliptaFluticasone/Umeclidin/Vilanter40$49,253
XareltoRivaroxaban45$28,827
LinzessLinaclotide30$24,277
RybelsusSemaglutide14$18,974
TwinrixHepatitis A And B Vaccine/Pf121$17,061
Breo ElliptaFluticasone/Vilanterol26$13,472

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerAbrysvo, Eliquis$467$1,053,2613,108 claims
GSKShingrix, Arexvy, Trelegy Ellipta, Twinrix, Breo Ellipta$946$666,8152,855 claims
Boehringer IngelheimJardiance, Spiriva Respimat, Tradjenta$315$84,376112 claims
Novo NordiskOzempic, Rybelsus$841$73,71762 claims
AstraZenecaFarxiga, Brilinta, Symbicort$1,155$66,49981 claims
MerckJanuvia$48$62,91576 claims
Johnson & JohnsonXarelto$598$28,82745 claims
AbbVieLinzess, Synthroid$168$28,394134 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 90 geriatric medicine providers in Virginia.

Other geriatric medicine in Abingdon

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →